BCAL Diagnostics 미래 성장
Future 기준 확인 5/6
BCAL Diagnostics is forecast to grow earnings and revenue by 90.6% and 77.6% per annum respectively while EPS is expected to grow by 99.2% per annum.
주요 정보
90.6%
수익 성장률
99.2%
EPS 성장률
Biotechs 수익 성장 | 15.2% |
매출 성장률 | 77.6% |
향후 자기자본 수익률 | n/a |
애널리스트 커버리지 | Low |
마지막 업데이트 | 13 Aug 2024 |
수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
6/30/2026 | 12 | 4 | 4 | 4 | 1 |
6/30/2025 | 3 | -7 | -7 | -7 | 1 |
6/30/2024 | 3 | -6 | -6 | -5 | N/A |
3/31/2024 | 3 | -6 | -5 | -4 | N/A |
12/31/2023 | 4 | -5 | -5 | -4 | N/A |
9/30/2023 | 3 | -5 | -6 | -5 | N/A |
6/30/2023 | 3 | -5 | -6 | -6 | N/A |
3/31/2023 | 2 | -5 | -6 | -5 | N/A |
12/31/2022 | 1 | -5 | -5 | -5 | N/A |
9/30/2022 | 1 | -4 | -4 | -4 | N/A |
6/30/2022 | 1 | -3 | -3 | -3 | N/A |
3/31/2022 | 1 | -3 | -3 | -3 | N/A |
12/31/2021 | 1 | -3 | -3 | -3 | N/A |
9/30/2021 | 0 | -2 | -2 | -2 | N/A |
6/30/2021 | 0 | -2 | -1 | -1 | N/A |
3/31/2021 | 0 | -1 | -1 | -1 | N/A |
12/31/2020 | 1 | 0 | 0 | 0 | N/A |
9/30/2020 | 0 | -1 | 0 | 0 | N/A |
6/30/2020 | 0 | -1 | -1 | -1 | N/A |
6/30/2019 | 0 | 0 | -1 | -1 | N/A |
6/30/2018 | 0 | 0 | 0 | 0 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: BDX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
수익 vs 시장: BDX is forecast to become profitable over the next 3 years, which is considered above average market growth.
고성장 수익: BDX is expected to become profitable in the next 3 years.
수익 대 시장: BDX's revenue (77.6% per year) is forecast to grow faster than the Australian market (5.7% per year).
고성장 수익: BDX's revenue (77.6% per year) is forecast to grow faster than 20% per year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: Insufficient data to determine if BDX's Return on Equity is forecast to be high in 3 years time